3D Bioprinting Market by Technology (Microextrusion, Inkjet, Laser, Magnetic), Material (Cells, Hydrogels, Extracellular Matrices, Biomaterials), Application (Clinical (Bone, Cartilage, Skin) & Research (Regenerative Medicine)) - Global Forecasts to 2021
The 3D bioprinting market is expected to reach USD 1,332.6 million by 2021, at a CAGR of 26.5% from 2016 to 2021.
The 3D bioprinting market is primarily driven by the rising demand for organ transplantation across the globe. In addition, growing R&D in the field of 3D bioprinting, increasing public and private investments to support 3D bioprinting research, and rising use of 3D bioprinting in drug discovery are supporting the growth of this market. On the other hand, limitations of biomaterial-based products and socio-ethical concerns are the major challenges in this market.
In this report, the 3D bioprinting market has been segmented on the basis of technology, applications (clinical and research applications), materials (living cells, hydrogels, extracellular matrices, and other biomaterials), and regions (North America, Europe, APAC, and the RoW). By technology, the global 3D bioprinting market is segmented into four categories, namely, microextrusion, laser-assisted, inkjet, and magnetic 3D bioprinting. The microextrusion 3D bioprinting market is estimated to command the largest share of the global market in 2016, due to its high affordability and simple setup process.
Geographically, North America (comprising the U.S. and Canada) is expected to command the largest share of the 3D bioprinting market in 2016, followed by Europe. Increasing government initiatives and rising demand for organ transplants are the major factors driving market growth in North America. However, the presence of a stringent regulatory process for the approval of 3D bioprinting products is a major factor restraining the growth of this regional segment.
The 3D bioprinting market consists of a number of big, medium-sized, and small companies. As of 2015, the syringes market is dominated by Organovo Holdings Inc. (U.S.), EnvisionTEC GmbH (Germany), and Nano3D Biosciences, Inc. (U.S.). Product launches, development, and commercialization; agreements; collaboration; and partnerships were the major strategies adopted by most of the market players between 2013 and 2016 to achieve growth in the 3D bioprinting market.
This report studies the 3D bioprinting market based on technology, application, and material. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four main regions.
Reasons to Buy the Report:
This research report focuses on various levels of analysis—industry trends, market ranking of top players, and company profiles—which together discuss basic views on the competitive landscape, emerging and high-growth segments of the 3D bioprinting market, and high-growth regions and their respective drivers, restraints, challenges, and opportunities.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies for strengthening its market shares.
The report provides insights on the following pointers:
Market Penetration: Comprehensive information on products and services offered by major players in the 3D bioprinting market. The report analyzes the 3D bioprinting market based on technology, application, material, and region
Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the 3D bioprinting market
Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various 3D bioprinting products across geographies
Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the 3D bioprinting market
Competitive Assessment: In-depth assessment of market shares, strategies, products & services, distribution networks, and manufacturing capabilities of leading players in the 3D bioprinting market